Tumor initiation at the pre-cancer stage is inhibited by SIRT1 based on increased DNA repair and genome stability, while SIRT1 promotes proliferation and survival at later stages of the tumor development, including metastasis and relapse by anti-apoptotic, pro-metabolism and anti-inflammatory mechanisms[137]. The gene discussed is SIRT1; the disease is cancer.